Spots Global Cancer Trial Database for cholangiocarcinoma of the gallbladder

Every month we try and update this database with for cholangiocarcinoma of the gallbladder cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Gemcitabine and Capecitabine in Treating Patients With Advanced and/or Inoperable Cholangiocarcinoma or Carcinoma of the Gallbladder	NCT00084942	Extrahepatic Bi... Gallbladder Can...	capecitabine gemcitabine hyd...	18 Years -	Roswell Park Cancer Institute
BMS-247550 in Treating Patients With Liver or Gallbladder Cancer	NCT00023946	Adult Primary C... Adult Primary H... Advanced Adult ... Cholangiocarcin... Cholangiocarcin... Localized Extra... Localized Gallb... Localized Resec... Localized Unres... Recurrent Adult... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga...	ixabepilone laboratory biom...	18 Years -	National Cancer Institute (NCI)
DX-8951f in Treating Patients With Biliary Cancer	NCT00005938	Extrahepatic Bi... Gallbladder Can... Liver Cancer	exatecan mesyla...	16 Years -	Daiichi Sankyo
Nal-IRI and 5-FU Compared to 5-FU in Patients With Cholangio- and Gallbladder Carcinoma Previously Treated With Gemcitabine-based Therapies	NCT03043547	Cholangiocarcin... Cholangiocarcin... Cholangiocarcin... Cholangiocarcin...	nal-IRI 5-FU leucovorin	18 Years -	AIO-Studien-gGmbH
S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangiocarcinoma	NCT00033540	Extrahepatic Bi... Gallbladder Can...	capecitabine gemcitabine hyd...	18 Years -	SWOG Cancer Research Network
S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangiocarcinoma	NCT00033540	Extrahepatic Bi... Gallbladder Can...	capecitabine gemcitabine hyd...	18 Years -	SWOG Cancer Research Network
Cediranib Maleate and Combination Chemotherapy in Treating Patients With Advanced Biliary Cancers	NCT01229111	Adult Primary C... Advanced Adult ... Cholangiocarcin... Cholangiocarcin... Localized Unres... Periampullary A... Recurrent Adult... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga...	cediranib malea... oxaliplatin leucovorin calc... fluorouracil	18 Years -	National Cancer Institute (NCI)
S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct	NCT00789958	Extrahepatic Bi... Gallbladder Can...	capecitabine gemcitabine hyd... 3-dimensional c... intensity-modul...	18 Years - 120 Years	SWOG Cancer Research Network
Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies	NCT01643499	Acinar Cell Ade... Adenocarcinoma ... Adenocarcinoma ... Adult Primary C... Advanced Adult ... Cholangiocarcin... Cholangiocarcin... Diffuse Adenoca... Duct Cell Adeno... Intestinal Aden... Localized Unres... Metastatic Carc... Metastatic Extr... Mixed Adenocarc... Mucinous Adenoc... Mucinous Adenoc... Newly Diagnosed... Signet Ring Ade... Signet Ring Ade... Stage III Pancr... Stage IIIA Colo... Stage IIIA Gall... Stage IIIA Gast... Stage IIIA Rect... Stage IIIB Colo... Stage IIIB Gall... Stage IIIB Gast... Stage IIIB Rect... Stage IIIC Colo... Stage IIIC Gast... Stage IIIC Rect... Stage IV Gastri... Stage IV Pancre... Stage IVA Colon... Stage IVA Gallb... Stage IVA Recta... Stage IVB Colon... Stage IVB Gallb... Stage IVB Recta... Unresectable Ex...	oxaliplatin irinotecan hydr... leucovorin calc... fluorouracil laboratory biom...	18 Years -	University of Chicago
Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer	NCT00363584	Extrahepatic Bi... Gallbladder Can... Liver Cancer	capecitabine clinical observ... adjuvant therap...	18 Years -	National Cancer Institute (NCI)
Bevacizumab and Erlotinib Hydrochloride in Treating Patients With Metastatic or Unresectable Biliary Tumors	NCT00356889	Cholangiocarcin... Cholangiocarcin... Gastrointestina... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga...	erlotinib hydro... bevacizumab	18 Years -	National Cancer Institute (NCI)
Biliary Stenting With or Without Photodynamic Therapy in Treating Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors That Cannot Be Removed by Surgery	NCT00513539	Extrahepatic Bi... Gallbladder Can...	porfimer sodium biliary stentin...	18 Years -	University College, London
Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer	NCT00027534	Breast Cancer Colorectal Canc... Gallbladder Can... Gastric Cancer Head and Neck C... Liver Cancer Ovarian Cancer Pancreatic Canc... Testicular Germ...	TRICOM-CEA(6D)	18 Years -	Duke University
BMS-247550 in Treating Patients With Liver or Gallbladder Cancer	NCT00023946	Adult Primary C... Adult Primary H... Advanced Adult ... Cholangiocarcin... Cholangiocarcin... Localized Extra... Localized Gallb... Localized Resec... Localized Unres... Recurrent Adult... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga...	ixabepilone laboratory biom...	18 Years -	National Cancer Institute (NCI)
Everolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable Solid Tumors Refractory to Standard Therapy	NCT00949949	Cholangiocarcin... Localized Gallb... Unresectable Ga... Unspecified Adu...	everolimus gemcitabine hyd... cisplatin	18 Years -	Mayo Clinic
Erlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder Cancer	NCT00033462	Adult Primary C... Adult Primary H... Advanced Adult ... Cholangiocarcin... Cholangiocarcin... Localized Unres... Recurrent Adult... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga...	erlotinib hydro... laboratory biom...	18 Years -	National Cancer Institute (NCI)
Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer	NCT00363584	Extrahepatic Bi... Gallbladder Can... Liver Cancer	capecitabine clinical observ... adjuvant therap...	18 Years -	National Cancer Institute (NCI)
Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer	NCT00003296	Extrahepatic Bi... Gallbladder Can... Liver Cancer	filgrastim pegylated lipos...	18 Years -	National Cancer Institute (NCI)
Bevacizumab and Erlotinib Hydrochloride in Treating Patients With Metastatic or Unresectable Biliary Tumors	NCT00356889	Cholangiocarcin... Cholangiocarcin... Gastrointestina... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga...	erlotinib hydro... bevacizumab	18 Years -	National Cancer Institute (NCI)
Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder Cancer	NCT00003557	Extrahepatic Bi... Gallbladder Can... Liver Cancer	dolastatin 10	18 Years -	University of Chicago
Gemcitabine With or Without Cisplatin in Treating Patients With Unresectable Locally Advanced or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors	NCT00262769	Extrahepatic Bi... Gallbladder Can...	cisplatin gemcitabine hyd...	16 Years -	University College, London
Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by Surgery	NCT01313377	Extrahepatic Bi... Gallbladder Can... Liver Cancer	gemcitabine hyd... oxaliplatin clinical observ... adjuvant therap... quality-of-life...	18 Years - 120 Years	UNICANCER
DX-8951f in Treating Patients With Biliary Cancer	NCT00005938	Extrahepatic Bi... Gallbladder Can... Liver Cancer	exatecan mesyla...	16 Years -	Daiichi Sankyo
S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangiocarcinoma	NCT00033540	Extrahepatic Bi... Gallbladder Can...	capecitabine gemcitabine hyd...	18 Years -	SWOG Cancer Research Network
DX-8951f in Treating Patients With Biliary Cancer	NCT00005938	Extrahepatic Bi... Gallbladder Can... Liver Cancer	exatecan mesyla...	16 Years -	Daiichi Sankyo
Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies	NCT01643499	Acinar Cell Ade... Adenocarcinoma ... Adenocarcinoma ... Adult Primary C... Advanced Adult ... Cholangiocarcin... Cholangiocarcin... Diffuse Adenoca... Duct Cell Adeno... Intestinal Aden... Localized Unres... Metastatic Carc... Metastatic Extr... Mixed Adenocarc... Mucinous Adenoc... Mucinous Adenoc... Newly Diagnosed... Signet Ring Ade... Signet Ring Ade... Stage III Pancr... Stage IIIA Colo... Stage IIIA Gall... Stage IIIA Gast... Stage IIIA Rect... Stage IIIB Colo... Stage IIIB Gall... Stage IIIB Gast... Stage IIIB Rect... Stage IIIC Colo... Stage IIIC Gast... Stage IIIC Rect... Stage IV Gastri... Stage IV Pancre... Stage IVA Colon... Stage IVA Gallb... Stage IVA Recta... Stage IVB Colon... Stage IVB Gallb... Stage IVB Recta... Unresectable Ex...	oxaliplatin irinotecan hydr... leucovorin calc... fluorouracil laboratory biom...	18 Years -	University of Chicago
S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct	NCT00789958	Extrahepatic Bi... Gallbladder Can...	capecitabine gemcitabine hyd... 3-dimensional c... intensity-modul...	18 Years - 120 Years	SWOG Cancer Research Network
Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer	NCT00003296	Extrahepatic Bi... Gallbladder Can... Liver Cancer	filgrastim pegylated lipos...	18 Years -	National Cancer Institute (NCI)
Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or Pancreas	NCT00003923	Extrahepatic Bi... Gallbladder Can... Liver Cancer Pancreatic Canc...	porfimer sodium	18 Years -	Memorial Sloan Kettering Cancer Center
Erlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder Cancer	NCT00033462	Adult Primary C... Adult Primary H... Advanced Adult ... Cholangiocarcin... Cholangiocarcin... Localized Unres... Recurrent Adult... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga...	erlotinib hydro... laboratory biom...	18 Years -	National Cancer Institute (NCI)
Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by Surgery	NCT01313377	Extrahepatic Bi... Gallbladder Can... Liver Cancer	gemcitabine hyd... oxaliplatin clinical observ... adjuvant therap... quality-of-life...	18 Years - 120 Years	UNICANCER
Everolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable Solid Tumors Refractory to Standard Therapy	NCT00949949	Cholangiocarcin... Localized Gallb... Unresectable Ga... Unspecified Adu...	everolimus gemcitabine hyd... cisplatin	18 Years -	Mayo Clinic
BMS-247550 in Treating Patients With Liver or Gallbladder Cancer	NCT00023946	Adult Primary C... Adult Primary H... Advanced Adult ... Cholangiocarcin... Cholangiocarcin... Localized Extra... Localized Gallb... Localized Resec... Localized Unres... Recurrent Adult... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga...	ixabepilone laboratory biom...	18 Years -	National Cancer Institute (NCI)
Biological Therapy in Treating Patients With Metastatic Cancer	NCT00004604	Breast Cancer Colorectal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Head and Neck C... Liver Cancer Lung Cancer Metastatic Canc... Ovarian Cancer Pancreatic Canc... Testicular Germ...	CEA RNA-pulsed ...	18 Years -	Duke University
Rebeccamycin Analogue in Treating Patients With Advanced Liver and/or Biliary Cancer	NCT00005997	Extrahepatic Bi... Gallbladder Can... Liver Cancer	becatecarin	18 Years -	Case Comprehensive Cancer Center

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: